The Centers for Disease Control and Prevention intends to issue a sole source purchase order to BioAutomation Corporation, 8408 Kenning Court, Plano, TX for a mid-throughput, high-capacity DNA synthesis instrument (12 columns in a single run), that offers the flexibility to handle different scales in each column position in the same run that also supports very large-scale columns, up to 100 umole. This instrument offers additional phosphoramidite ports for special chemistry needs. The particular instrument considered, the BioAutomation Mermade 12, can produce up to 12 different DNA synthesis products of various scales simultaneously. It also supports ten additional non-standard amidite bottle locations for synthesis, allowing plenty of room for accommodating new technologies which might require a number of auxiliary positions. This system can accommodate synthesis scales from fifty (5)) umoles to 100 umoles (=100,000 nmoles), which will enable the laboratory to scale up to unpredecented proprotions should it become necessary. CDC believes that this requirement is met by only one provider. This procurement will be processed under the authority of FAR 6.302-1 and 6.302-2. Only one responsible source and no other sources will satisfy agency requirements. No solicitation is being issued. Interested persons may identify their interest and capability to respond to this requirement. This procurement is not set-aside for small business. For contractual questions contact Linda M. Young.

Bid Protests Not Available